background
aim
war
far
narr
review
attempt
describ
problem
manag
induc
acut
respiratori
failur
arf
pulmonologist
method
search
follow
databas
medlin
embas
cochran
world
race
contain
spread
updatedr
time
medic
inform
reach
high
rank
journal
faster
ever
still
lot
question
unansw
huge
effort
made
countri
allow
us
gain
critic
time
better
prepar
increas
awar
fact
reflect
could
help
pulmonologist
tackl
current
pandem
report
china
suggest
mild
sever
requir
intens
care
mortal
rate
seri
publish
china
itali
us
rang
hospit
critic
ill
patient
frame
role
pulmonologist
increas
narr
review
tri
describ
problem
manag
induc
acut
respiratori
failur
arf
pulmonologist
remain
awar
overflow
new
inform
may
make
report
rapidli
obsolet
search
follow
databas
medlin
embas
cochran
central
regist
control
trial
april
languag
restrict
also
review
refer
retriev
articl
addit
ersat
clinic
practic
guidelin
recommend
firmli
niv
prevent
strategi
avoid
intub
hypoxaem
arf
perform
experienc
team
highli
select
cooper
patient
communityacquir
pneumonia
earli
ard
without
associ
major
organ
dysfunct
patient
de
novo
arf
niv
larg
expiratori
tidal
volum
vte
may
gener
assist
pressur
control
mode
ventil
pressur
one
gener
respiratori
muscl
therefor
reliabl
monitor
vte
unintent
leak
would
outmost
import
use
icu
ventil
driven
high
pressur
doubl
limb
configur
leak
comput
differ
inspir
tidal
volum
vte
consequ
amount
tidal
volum
patient
get
usual
quantifi
vte
major
patient
de
novo
moderatetosever
hypoxaemia
target
vte
mlkg
imposs
achiev
niv
humidifi
mask
icu
ventil
higher
vte
independ
associ
niv
failur
subgroup
patient
arteri
oxygen
tension
inspiratori
oxygen
fraction
ratio
mean
vte
higher
mlkg
first
four
cumul
hour
niv
accur
predict
niv
failur
higher
vte
independ
associ
niv
failur
subgroup
patient
arteri
oxygen
tension
inspiratori
oxygen
fraction
ratio
mean
vte
higher
mlkg
first
four
cumul
hour
niv
accur
predict
niv
failur
recent
random
control
trial
patel
et
al
significantli
compar
niv
deliv
via
facial
mask
respect
helmet
seem
effect
toler
interfac
set
would
make
sens
evalu
stand
compar
hfnc
inde
recent
physiolog
random
crossov
studi
conclud
patient
highpeep
helmet
niv
could
prefer
hfnc
optim
oxygen
mitig
inspiratori
effort
especi
sever
hypoxaem
patient
exhibit
intens
inspiratori
effort
hfnc
caution
need
patient
low
inspiratori
effort
hfnc
experi
increas
dynam
transpulmonari
drive
pressur
niv
helmet
recent
systemat
review
show
compar
convent
oxygen
therapi
hfnc
decreas
risk
requir
intub
without
impact
mortal
author
point
flow
rate
variabl
studi
also
durat
treatment
analys
physiolog
random
control
studi
show
higher
flow
better
physiolog
respons
ad
prone
posit
hfnc
riera
et
al
riera
et
al
demonstr
healthi
subject
lead
homogen
distribut
endexpiratori
lung
imped
possibl
translat
better
oxygen
awak
nonintub
spontan
breath
patient
hypoxaem
arf
majorli
immunocompromis
scaravilli
et
al
show
signific
improv
prone
posit
recent
earli
prone
posit
ad
hfnc
niv
avoid
need
intub
half
patient
moder
sever
ard
includ
viral
pneumonia
health
care
profession
infect
studi
carri
isol
neg
pressur
room
author
report
similar
result
random
control
trial
ongo
frat
jp
et
al
patient
studi
effect
sequenti
applic
session
hfnc
niv
intub
requir
patient
includ
individu
ard
author
conclud
due
good
toler
efficaci
oxygen
hfnc
could
good
option
use
niv
session
pursu
coupl
non
invas
strategi
ventil
without
mark
impair
oxygen
choos
best
respiratori
support
patient
arf
need
understand
risk
differ
intervent
systemat
review
conclud
consist
associ
increas
risk
sar
transmiss
profession
tracheal
intub
mask
ventil
also
posit
associ
studi
data
consid
suffici
robust
establish
firm
conclus
shown
tabl
bench
studi
show
dispers
exhal
air
differ
depend
respiratori
therapi
interfac
nasal
cannula
oronas
mask
helmet
oxygen
deliv
lmin
mild
lung
injuri
increas
larg
droplet
seen
use
niv
circuit
modif
nonvent
mask
exhal
filter
oxygen
therapi
increas
droplet
count
size
rang
studi
might
conclud
niv
helmet
doubl
limb
circuit
good
seal
neckhelmet
interfac
would
safe
option
manag
infecti
patient
hypoxaem
arf
altern
studi
come
mention
laboratori
show
hfnc
model
airvo
fisher
exhal
air
mean
distanc
increas
mm
flow
increas
shorter
distanc
applic
cpap
commonli
use
nasal
pillow
moreov
air
leakag
mm
occur
later
hfnc
interfac
tube
becam
loos
analyz
current
trend
niv
hfnc
usag
publish
seri
major
journal
show
follow
mean
niv
usag
hospit
patient
china
higher
seri
includ
critic
ill
moder
sever
one
seri
pneumonia
case
itali
usa
mean
hfnc
usag
china
rage
page
j
u
r
n
l
p
r
e
p
r
f
higher
seri
includ
critic
ill
moder
sever
itali
usa
higher
critic
ill
seattl
real
world
studi
two
chongq
hospit
china
patient
experienc
sever
arf
patient
treat
hfnc
firstlin
therapi
treat
niv
treat
invas
ventil
hfnc
patient
experienc
failur
failur
rate
patient
one
import
issu
hfnc
amount
condens
circuit
increas
ambient
temperatur
decreas
present
condens
water
becom
import
sourc
infect
avoid
reduct
condens
may
import
hfnc
use
bacteri
contamin
inner
surfac
circuit
termin
hfnc
shown
case
mainli
occur
interfac
end
figur
high
anesthet
breath
circuit
decreas
circuit
fit
heat
wire
greatli
reduc
condens
although
evid
recent
seri
lack
singl
mention
transmiss
profession
techniqu
author
recommend
niv
hfnc
patient
clear
howev
experi
china
suggest
earli
intervent
hfnc
niv
associ
prone
posit
lead
lower
mortal
less
case
need
intub
versu
nation
averag
option
differ
scientif
societi
tabl
non
invas
ventil
hfnc
reserv
patient
mild
ard
close
monitor
airborn
precaut
prefer
singl
room
patient
suspect
diagnos
requir
niv
helmet
may
best
solut
cpap
niv
minim
dispers
leak
easi
filterscaveng
exhaust
ga
due
scarciti
interfac
probabl
tradit
oronas
mask
commonli
use
case
suboptim
niv
setup
interfac
inappropri
seal
improp
circuitri
toler
niv
option
tri
protectiveniv
lower
tidal
volum
mlkg
simpl
descript
problem
narr
review
elicit
need
innov
strategi
addit
medic
therapi
vaccin
campaign
respiratori
therapi
repres
risk
aerosol
gener
procedur
care
patient
person
protect
equip
environment
controlengin
initi
concern
consider
manag
patient
given
current
circumst
like
random
control
trial
confirm
non
invas
respiratori
support
better
reduc
need
intub
context
pandem
manufactur
urg
creat
safer
interfac
viral
proof
circuitri
new
gener
non
invas
ventil
integr
differ
therapi
specif
monitor
necessari
safeti
featur
impress
marathon
sprint
like
david
must
beat
goliath
tabl
exhal
air
dispers
accord
modal
interfac
interfac
pressur
resm
figur
power
air
purifi
respir
cleanspac
cleanspac
technolog
pti
ltd
artarmon
nsw
australia
niosh
us
atex
europ
approv
